These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29061990)

  • 1. TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function.
    Gruppen EG; Garcia E; Connelly MA; Jeyarajah EJ; Otvos JD; Bakker SJL; Dullaart RPF
    Sci Rep; 2017 Oct; 7(1):13781. PubMed ID: 29061990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
    Winther SA; Øllgaard JC; Tofte N; Tarnow L; Wang Z; Ahluwalia TS; Jorsal A; Theilade S; Parving HH; Hansen TW; Hazen SL; Pedersen O; Rossing P
    Diabetes Care; 2019 Aug; 42(8):1512-1520. PubMed ID: 31123156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
    Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
    Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
    PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of trimethylamine
    Zhang P; Zou JZ; Chen J; Tan X; Xiang FF; Shen B; Hu JC; Wang JL; Wang YQ; Yu JB; Nie YX; Chen XH; Yu JW; Zhang Z; Lv WL; Xie YQ; Cao XS; Ding XQ
    Ren Fail; 2020 Nov; 42(1):1004-1014. PubMed ID: 32985309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal microbiota-dependent phosphatidylcholine metabolites, diastolic dysfunction, and adverse clinical outcomes in chronic systolic heart failure.
    Tang WH; Wang Z; Shrestha K; Borowski AG; Wu Y; Troughton RW; Klein AL; Hazen SL
    J Card Fail; 2015 Feb; 21(2):91-6. PubMed ID: 25459686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota-derived trimethylamine N-oxide is associated with poor prognosis in patients with heart failure.
    Li W; Huang A; Zhu H; Liu X; Huang X; Huang Y; Cai X; Lu J; Huang Y
    Med J Aust; 2020 Oct; 213(8):374-379. PubMed ID: 32959366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating trimethylamine-N-oxide is associated with all-cause mortality in subjects with nonalcoholic fatty liver disease.
    Flores-Guerrero JL; Post A; van Dijk PR; Connelly MA; Garcia E; Navis G; Bakker SJL; Dullaart RPF
    Liver Int; 2021 Oct; 41(10):2371-2382. PubMed ID: 33993608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethylamine-N-oxide and 5-year mortality: the role of gut microbiota-generated metabolite from the CORE-Thailand cohort.
    Senthong V; Kiatchoosakun S; Wongvipaporn C; Phetcharaburanin J; Sritara P; Phrommintikul A;
    Sci Rep; 2024 Sep; 14(1):21264. PubMed ID: 39261513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethylamine N-Oxide and Risk of Cardiovascular Disease and Mortality.
    Kanitsoraphan C; Rattanawong P; Charoensri S; Senthong V
    Curr Nutr Rep; 2018 Dec; 7(4):207-213. PubMed ID: 30362023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus.
    Yu PS; Wu PH; Hung WW; Lin MY; Zhen YY; Hung WC; Chang JM; Tsai JR; Chiu YW; Hwang SJ; Tsai YC
    J Clin Endocrinol Metab; 2024 Jul; 109(8):2097-2105. PubMed ID: 38267025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Trimethylamine N-Oxide and Risk of Cardiovascular Events in Patients With Type 2 Diabetes.
    Croyal M; Saulnier PJ; Aguesse A; Gand E; Ragot S; Roussel R; Halimi JM; Ducrocq G; Cariou B; Montaigne D; Wargny M; Krempf M; Hadjadj S
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32301490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Uremic Solutes With Cardiovascular Death in Diabetic Kidney Disease.
    Sapa H; Gutiérrez OM; Shlipak MG; Katz R; Ix JH; Sarnak MJ; Cushman M; Rhee EP; Kimmel PL; Vasan RS; Schrauben SJ; Feldman HI; Seegmiller JC; Brunengraber H; Hostetter TH; Schelling JR;
    Am J Kidney Dis; 2022 Oct; 80(4):502-512.e1. PubMed ID: 35351578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis.
    Schiattarella GG; Sannino A; Toscano E; Giugliano G; Gargiulo G; Franzone A; Trimarco B; Esposito G; Perrino C
    Eur Heart J; 2017 Oct; 38(39):2948-2956. PubMed ID: 29020409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis.
    Kaysen GA; Johansen KL; Chertow GM; Dalrymple LS; Kornak J; Grimes B; Dwyer T; Chassy AW; Fiehn O
    J Ren Nutr; 2015 Jul; 25(4):351-6. PubMed ID: 25802017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut, microbiota-dependent trimethylamine-N-oxide is associated with long-term all-cause mortality in patients with exacerbated chronic obstructive pulmonary disease.
    Ottiger M; Nickler M; Steuer C; Bernasconi L; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
    Nutrition; 2018 Jan; 45():135-141.e1. PubMed ID: 28870405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma trimethylamine n-oxide is associated with renal function in patients with heart failure with preserved ejection fraction.
    Guo F; Qiu X; Tan Z; Li Z; Ouyang D
    BMC Cardiovasc Disord; 2020 Aug; 20(1):394. PubMed ID: 32859154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis.
    Tang WH; Wang Z; Fan Y; Levison B; Hazen JE; Donahue LM; Wu Y; Hazen SL
    J Am Coll Cardiol; 2014 Nov; 64(18):1908-14. PubMed ID: 25444145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trimethylamine N-oxide is associated with long-term mortality risk: the multi-ethnic study of atherosclerosis.
    Wang M; Li XS; Wang Z; de Oliveira Otto MC; Lemaitre RN; Fretts A; Sotoodehnia N; Budoff M; Nemet I; DiDonato JA; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    Eur Heart J; 2023 May; 44(18):1608-1618. PubMed ID: 36883587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.